Tcr2 Therapeutics Inc (TCRR) Up 45.45% in Premarket Trading

Monday, March 06, 2023 06:45 AM | InvestorsObserver Analysts

Mentioned in this article

Tcr2 Therapeutics Inc (TCRR) Up 45.45% in Premarket Trading

Tcr2 Therapeutics Inc (TCRR) is up Monday morning, with the stock increasing 45.45% in pre-market trading to 1.76. TCRR's short-term technical score of 24 indicates that the stock has traded less bullishly over the last month than 76% of stocks on the market. In the Biotechnology industry, which ranks 114 out of 146 industries, Tcr2 Therapeutics Inc ranks higher than 33% of stocks. Tcr2 Therapeutics Inc has fallen 15.97% over the past month, closing at $1.41 on February 6. During this period of time, the stock fell as low as $1.10 and as high as $1.47. TCRR has an average analyst recommendation of Strong Buy. The company has an average price target of $8.14.

TCRR has an Overall Score of 45. Find out what this means to you and get the rest of the rankings on TCRR!

See Full TCRR Report

Tcr2 Therapeutics Inc has a Long-Term Technical rank of 17. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 83% of the market scoring higher. In the Biotechnology industry which is number 129 by this metric, TCRR ranks better than 129% of stocks.

Important Dates for Investors in TCRR:

-Tcr2 Therapeutics Inc is set to release earnings on 3/28/2023. Over the last 12 months, the company has reported EPS of $-3.09. -We do not have a set dividend date for Tcr2 Therapeutics Inc at this time. Click Here To Get The Full Report on Tcr2 Therapeutics Inc (TCRR)